EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Cytokine, Metabolic, and Proliferative Profiling Reveals Divergent Metabolic and Proliferative Responses in Papillary Thyroid Cancer Cells

Angelika Buczyńska-Backiel iD, Julia Redlińska, Julia Zając, Maria Kościuszko, Agnieszka Adamska, Katarzyna Siewko, Anna Popławska-Kita iD, Adam Jacek Krętowski iD

International Journal of Molecular Sciences · 09.07.2026 · 27 (14) · 6131

DOI: 10.3390/ijms27146131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.07.2026. Verfasst von Angelika Buczyńska-Backiel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Centre, Medical University of Bialystok, 15-276 Bialystok, Poland. Hauptthemen laut MEDLINE: Cytokines, Thyroid Cancer, Papillary, Thyroid Neoplasms. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCN, Medical University of Bialystok, National Science Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Papillary thyroid cancer (PTC) exhibits Warburg-type metabolic reprogramming with enhanced glycolysis and dependence on glucose-driven pathways. This study evaluated the effects of antihyperglycemic interventions on cytokine secretion, angiogenic signaling, metabolic activity, and proliferation in thyroid-derived cell models. Two PTC cell lines (MDA-T32 and SCC147) and a normal thyroid line (Nthy-ori) were analyzed for intracellular and extracellular cytokines, secretion efficiency (index), relative metabolic index (RMI), and marker of proliferation (Ki-67) expression following exposure to vandetanib (VDT), sodium–glucose cotransporter 2 (SGLT2), or dipeptidyl peptidase (DPP) inhibitors. Baseline analysis revealed distinct cell line-specific profiles. Compared with Nthy-ori cells, MDA-T32 cells exhibited increased vascular endothelial growth factor (VEGF) concentrations in lysates and conditioned medium (p < 0.001, q < 0.001) with enhanced VEGF secretion efficiency (p = 0.002, q = 0.008), elevated intracellular fibroblast growth factor (FGF) (p < 0.001, q < 0.001) with reduced FGF secretion index (p = 0.004, q = 0.01), and lower interleukin 8 (IL-8) concentrations accompanied by increased IL-8 secretion efficiency (p = 0.006, q = 0.02). In contrast, SCC147 cells demonstrated reduced VEGF secretion (p < 0.001, q < 0.001), decreased intracellular IL-8 (p = 0.008, q = 0.02), reduced chemokines of the growth-regulated oncogene GROβ family (GROβ) secretion (p = 0.01, q = 0.04), increased IL-8 secretion efficiency (p = 0.01, q = 0.03), and decreased GROβ secretion efficiency (p = 0.008, q = 0.02). Nthy-ori cells displayed a balanced profile. Among the investigated interventions, VDT produced the most pronounced effects. In MDA-T32 cells, VDT significantly reduced VEGF levels (p < 0.001, q < 0.001) and increased IL-8 and GROβ concentrations in conditioned medium (q < 0.05), whereas no significant effects after FDR correction were observed in SCC147 or Nthy-ori cells. SGLT2 and DPP inhibitors produced only nominal effects (p < 0.05), which did not remain significant after correction for multiple testing. VDT reduced RMI by approximately 50% in MDA-T32 cells while Ki-67 expression increased, whereas SCC147 cells remained largely unchanged. In Nthy-ori cells, SGLT2 inhibition increased RMI and decreased Ki-67 expression. These findings demonstrate marked heterogeneity among PTC cell lines and suggest that alterations in metabolic activity were not consistently accompanied by proportional changes in proliferative status under the experimental conditions used. VDT predominantly affected angiogenic and inflammatory signaling in MDA-T32 cells, whereas SGLT2 and DPP inhibition exerted limited measurable effects at clinically achievable concentrations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesThyroid Cancer, PapillaryThyroid NeoplasmsHumansCell ProliferationCell Line, TumorVascular Endothelial Growth Factor AQuinazolinesMetabolic ReprogrammingSodium-Glucose Transporter 2Piperidines

Stichwörter der Autor:innen

DPP inhibitionSGLT2 inhibitionangiogenesiscytokinesinflammationmetabolismpapillary thyroid cancer

Substanzen

CytokinesVascular Endothelial Growth Factor AQuinazolinesvandetanibSodium-Glucose Transporter 2Piperidines

Autor:innen und Institutionen

  • Clinical Research Centre, Medical University of Bialystok, 15-276 Bialystok, Poland.
  • Department of Gynecological Endocrinology and Adolescent Gynecology, Medical University of Białystok, 15-276 Białystok, Poland.
  • Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, 15-276 Bialystok, Poland.

ORCID-Profile: Angelika Buczyńska-Backiel, Anna Popławska-Kita, Adam Jacek Krętowski

Förderung

  • NCN
  • Medical University of Bialystok
  • National Science Centre

Zitieren

APA

Buczyńska-Backiel, A., Redlińska, J., Zając, J., Kościuszko, M., Adamska, A., Siewko, K., Popławska-Kita, A., & Krętowski, A. J. (2026). Integrated Cytokine, Metabolic, and Proliferative Profiling Reveals Divergent Metabolic and Proliferative Responses in Papillary Thyroid Cancer Cells. International Journal of Molecular Sciences, 27(14), 6131. https://doi.org/10.3390/ijms27146131

Vancouver

Buczyńska-Backiel A, Redlińska J, Zając J, Kościuszko M, Adamska A, Siewko K, et al. Integrated Cytokine, Metabolic, and Proliferative Profiling Reveals Divergent Metabolic and Proliferative Responses in Papillary Thyroid Cancer Cells. International Journal of Molecular Sciences. 2026;27(14):6131. doi:10.3390/ijms27146131

BibTeX
@article{BuczyskaBackiel2026,
  author = {Buczyńska-Backiel, Angelika and Redlińska, Julia and Zając, Julia and Kościuszko, Maria and Adamska, Agnieszka and Siewko, Katarzyna and Popławska-Kita, Anna and Krętowski, Adam Jacek},
  title = {Integrated Cytokine, Metabolic, and Proliferative Profiling Reveals Divergent Metabolic and Proliferative Responses in Papillary Thyroid Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6131},
  doi = {10.3390/ijms27146131}
}
Kostenlos starten →